Christophe Maritaz
Paris, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Ezabenlimab and induction chemotherapy followed by adaptive chemoradiotherapy in patients with stage 3 squamous cell anal carcinoma (INTERACT-ION): an open-label, single-arm, phase 2 trial.
Journal: The Lancet. Oncology
Published: August 08, 2025
Nivolumab plasma concentration and clearance associated with overall survival in patients with renal cell carcinoma.
Journal: Journal for immunotherapy of cancer
Published: November 23, 2024
Characterization of Patients with EGFR Mutation-Positive NSCLC Following Emergence of the Osimertinib Resistance Mutations, L718Q or G724S: A Multicenter Retrospective Observational Study in France.
Journal: OncoTargets and therapy
Published: November 17, 2023
Phase II INTERACT-ION study: ezabenlimab (BI 754091) and mDCF (docetaxel, cisplatin, and 5-fluorouracil) followed by chemoradiotherapy in patients with Stage III squamous cell anal carcinoma.
Journal: Frontiers in oncology
Published: April 12, 2022
Immune checkpoint-targeted antibodies: a room for dose and schedule optimization?
Journal: Journal of hematology & oncology
Published: May 18, 2021
Patients on oral anticancer drugs and coordinated pathway: CHIMORAL, feedback from care providers
Journal: Bulletin du cancer
Published: June 14, 2020
Treatment sequence of first and second generation tyrosine kinase inhibitor followed by osimertinib in EGFR-mutated non-small-cell lung cancer: a real life study.
Journal: Future oncology (London, England)
Published: May 01, 2020
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 2, immune checkpoint inhibitor antibodies.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 10, 2019
Pharmacokinetic/pharmacodynamic relationship of therapeutic monoclonal antibodies used in oncology: Part 1, monoclonal antibodies, antibody-drug conjugates and bispecific T-cell engagers.
Journal: European journal of cancer (Oxford, England : 1990)
Published: November 10, 2019
Impact of a coordinated regional organization to secure the management of patients on oral anticancer drugs: CHIMORAL, a comparative trial
Journal: Bulletin du cancer
Published: December 04, 2018
High-dose thiotepa-related neurotoxicity and the role of tramadol in children.
Journal: BMC cancer
Published: February 22, 2017
Cetuximab-induced aseptic meningitis: case report and review of a rare adverse event.
Journal: BMC cancer
Published: September 22, 2015
Last Updated: 09/26/2026